Pub. Date : 1997 Oct
PMID : 9357856
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Both SNP (10(-6) to 10(-3) M) and SNAP (10(-6) to 10(-3) M) caused concentration-dependent elevation of cGMP in the presence of the nonselective phosphodiesterase (PDE) inhibitor 3-isobutyl-1-methylxanthine (10(-3) M), with cGMP increasing 6- and 15-fold in response to SNP and SNAP, respectively, at the highest concentration tested (10(-3) M). | Cyclic GMP | aldehyde dehydrogenase 7 family member A1 | Homo sapiens |
2 | Both SNP (10(-6) to 10(-3) M) and SNAP (10(-6) to 10(-3) M) caused concentration-dependent elevation of cGMP in the presence of the nonselective phosphodiesterase (PDE) inhibitor 3-isobutyl-1-methylxanthine (10(-3) M), with cGMP increasing 6- and 15-fold in response to SNP and SNAP, respectively, at the highest concentration tested (10(-3) M). | Cyclic GMP | aldehyde dehydrogenase 7 family member A1 | Homo sapiens |
3 | SNAP- and ANP-induced cGMP accumulation was increased by the selective type V PDE inhibitors SKF-96231 and zaprinast, suggesting that type V PDE is responsible for cGMP breakdown in HASMC. | Cyclic GMP | aldehyde dehydrogenase 7 family member A1 | Homo sapiens |
4 | SNAP- and ANP-induced cGMP accumulation was increased by the selective type V PDE inhibitors SKF-96231 and zaprinast, suggesting that type V PDE is responsible for cGMP breakdown in HASMC. | Cyclic GMP | aldehyde dehydrogenase 7 family member A1 | Homo sapiens |
5 | SNAP- and ANP-induced cGMP accumulation was increased by the selective type V PDE inhibitors SKF-96231 and zaprinast, suggesting that type V PDE is responsible for cGMP breakdown in HASMC. | Cyclic GMP | aldehyde dehydrogenase 7 family member A1 | Homo sapiens |
6 | SNAP- and ANP-induced cGMP accumulation was increased by the selective type V PDE inhibitors SKF-96231 and zaprinast, suggesting that type V PDE is responsible for cGMP breakdown in HASMC. | Cyclic GMP | aldehyde dehydrogenase 7 family member A1 | Homo sapiens |